Na+/Ca2+ exchange inhibitors: Potential drugs to mitigate the severity of ischemic injury

Molecular Pharmacology

Volumn 66, Issue 1, 2004, Pages 8-10

  Akabas, Myles H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; 2 [4 (4 NITROBENZYLOXY)BENZYL]THIAZOLIDINE 4 CARBOXYLIC ACID ETHYL ESTER; CALCIUM BINDING PROTEIN; CALCIUM ION; POTASSIUM CHANNEL; PROTEIN INHIBITOR; SN 6; SODIUM CALCIUM EXCHANGE PROTEIN; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG; 2 (2 (4 (4 NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; 2-(2-(4-(4-NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; ANILINE DERIVATIVE; ANTIARRHYTHMIC AGENT; DIPHENYL ETHER DERIVATIVE; DRUG DERIVATIVE; THIOUREA;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DAMAGE; CELL HYPOXIA; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GENETIC CODE; HEART MUSCLE POTENTIAL; HUMAN GENOME; ISCHEMIA; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPERFUSION INJURY; REVIEW; SODIUM CALCIUM EXCHANGE; TISSUE OXYGENATION; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; HEART; HUMAN;

ANILINE COMPOUNDS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; HEART; HUMANS; MYOCARDIAL REPERFUSION INJURY; PHENYL ETHERS; SODIUM-CALCIUM EXCHANGER; THIOUREA;

EID: 3042621420     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.000232.     Document Type: Review

References (39)

1. + exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 39:747-753.
2. 2+ overload during hypoxia-reoxygenation in rat ventricular myocytes. J Physiol 550:889-898.
3. Banasiak KJ, Xia Y, and Haddad GG (2000) Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 62:215-249.
4. Blaustein MP and Lederer WJ (1999) Sodium/calcium exchange: its physiological implications. Physiol Rev 79:763-854.
5. 2+ exchangers with altered ionic regulation. Mol Pharmacol 65: 802-810.
6. Corti R, Farkouh ME, and Badimon JJ (2002) The vulnerable plaque and acute coronary syndromes. Am J Med 113:668-680.
7. Craner MJ, Hains BC, Lo AC, Black JA, and Waxman SG (2004) Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 127:294-303.
8. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83:1215-1223.
9. 2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences. Am J Physiol 281: H1334-H1345.
10. 2+ exchanger expression in the developing rat cortex. Neuroscience 112:65-73.
11. + channels. Adv Exp Med Biol 475:441-452.
12. 2 with the XIP region of the cardiac Na/Ca exchanger. Am J Physiol 278:C661-C666.
13. Hilgemann DW (2003) Getting ready for the decade of the lipids. Annu Rev Physiol 85:697-700.
14. 2+ exchanger. Nature (Lond) 352:715-718.
15. Imahashi K, Kusuoka H, Hashimoto K, Yoshioka J, Yamaguchi H, and Nishimura T (1999) Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 84:1401-1406.
16. 2+ exchange (NCX1) by SN-6, a novel benzyloxyphenyl derivative. Mol Pharmacol 66:45-55.
17. 2+ exchange in cells expressing NCX1. J Biol Chem 271:22391-22397.
18. 2+ exchanger 2. Neuron 38:965-976.
19. 2+ exchanger. Nature (Lond) 427:544-548.
20. 2+ exchanger. Am J Physiol 276:H1868-H1876.
21. Li C and Jackson RM (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol 282:C227-C241.
22. 2+ exchanger. J Biol Chem 266:1014-1020.
23. 2+ exchanger inhibitors SEA0400 and KB-R7943. Am J Physiol 284:H903-H910.
24. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298:249-256.
25. + exchanger for protection of the myocardium from lethal reperfusion injury. Cardiovasc Drugs Ther 16:295-301.
26. ++ exchanger and myocardial ischemia/reperfusion. Jpn Heart J 39:707-714.
27. Nasuhoglu C, Feng S, Mao Y, Sbammat I, Yamamato M, Earnest S, Lemmon M, and Hilgemann DW (2002) Modulation of cardiac PIP2 by cardioactive hormones and other physiologically relevant interventions. Am J Physiol 283:C223-C234.
28. 2+ exchanger knockout mouse model. Biochem Biophys Res Commun 314:849-853.
29. Orrenius S, Zhivotovsky B, and Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552-565.
30. Philipson KD and Nicoll DA (2000) Sodium-calcium exchange: a molecular perspective. Annu Rev Physiot 62:111-133.
31. 2+ exchange molecule: an overview. Ann NY Acad Sci 976:1-10.
32. 2+ exchanger. J Biol Chem 276:194-199.
33. 2+ exchange inhibitors. Circ Res 91:90-92.
34. 2+ exchanger is essential for the action of cardiac glycosides. Circ Res 90:305-308.
35. 2+ exchange: molecular and pharmacological aspects. Circ Res 88:864-876.
36. 2+ exchanger. J Neurosci 12:430-439.
37. 2+ exchanger after traumatic or hypoxic/ischemic injury to spinal cord white matter. Spine J 2:35-40.
38. 2+ exchanger. J Pharmacol Exp Ther 304:284-293.
39. 2+ exchange. Circ Res 90:988-995.